BioMerieux SA (OTCMKTS:BMXMF) shot up 3.6% on Wednesday . The stock traded as high as $85.44 and last traded at $84.75, 106 shares traded hands during trading. The stock had previously closed at $81.80.
Separately, Zacks Investment Research cut BioMerieux from a “buy” rating to a “hold” rating in a research report on Tuesday, April 30th.
The company has a 50-day moving average price of $82.94.
bioMérieux SA provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company offers microbiology technology that involves culturing biological samples; and immunoassays technology based on antigen-antibody reaction, detects and measures infectious agents, such as bacteria, viruses, and parasites, as well as measures the specific biomarkers of various pathologies, such as metabolic, hormonal, infectious, etc.
Featured Story: What does it mean to hold a stock in street name?
Receive News & Ratings for BioMerieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioMerieux and related companies with MarketBeat.com's FREE daily email newsletter.